Results 251 to 260 of about 2,327,584 (298)
Some of the next articles are maybe not open access.

Brain metastases

Current Opinion in Neurology, 2005
Brain metastases occur in 10-30% of cancer patients, and they are associated with a dismal prognosis. Radiation therapy has been the mainstay of treatment for patients without surgically treatable lesions. For patients with good prognostic factors and a single metastasis, surgical resection is recommended.
Andrew D, Norden   +2 more
openaire   +2 more sources

Brain Metastases

Neurologic Clinics, 2007
Brain metastases are a common complication of cancer and alter patient management more than metastases at any other site of distant progression. Supportive therapies include steroids and antiseizure medications. Definitive treatments include radiation therapy, surgery, and chemotherapy.
Teri D, Nguyen, Lisa M, DeAngelis
openaire   +2 more sources

Brain metastases

Neurologic Clinics, 2003
Brain metastases are one of the most feared complications of cancer because even small tumors may cause incapacitating neurologic symptoms. This article reviews the epidemiology, clinical features, treatment, and prognosis of brain metastases from system malignancies.
Andrew B, Lassman, Lisa M, DeAngelis
openaire   +2 more sources

Brain Metastases

Neurologic Clinics, 1991
Brain metastases are the most common intracranial tumors and affect 20% to 30% of patients with systemic cancer. Improvements in diagnostic imaging and recent advances in treatment have resulted in extension of survival and decreased morbidity due to neurologic causes.
openaire   +2 more sources

Brain metastases

Current Treatment Options in Oncology, 2001
Metastatic tumors to the brain are an increasing cause of morbidity and mortality in patients with systemic cancers. Many new therapies used to treat systemic cancers do not penetrate the central nervous system (CNS) and do not protect patients from the development of brain metastases.
M G, Ewend   +4 more
openaire   +2 more sources

Brain metastases

Current Treatment Options in Oncology, 2000
Brain metastases are an increasingly common complication in patients with systemic cancer. The optimal treatment for each patient depends on careful evaluation of several factors: the location, size, and number of brain metastases; the patient's age, general condition, and neurologic status; and the extent of systemic cancer to name a few. For patients
P Y, Wen, J S, Loeffler
openaire   +2 more sources

Brain metastases

Current Treatment Options in Neurology, 2008
Metastatic brain tumors are the most common intracranial neoplasm in adults, affecting up to 10% of adults with cancer in the United States. The risk of developing brain metastases varies by primary cancer type, with lung cancer, breast cancer, and melanoma accounting for the majority.
April F, Eichler, Scott R, Plotkin
openaire   +2 more sources

Brain metastases

Current Problems in Cancer, 1999
The topic of brain metastases has recently become a popular subject for review. The reasons for this most likely include technical advances in therapy, notably radiosurgery, as well as recently-published reports of phase III studies, which have addressed certain aspects of management, notably the combination of surgery and radiotherapy in the treatment
openaire   +2 more sources

Radiotherapy of brain metastases

International Journal of Radiation Oncology*Biology*Physics, 1986
The effect of radiotherapy in 254 cases of brain metastases, treated between 1977 and 1984, were studied. The cases included 141 of lung cancer, 28 of mammary cancer, and 85 of other primary sites. The percentages of patients with improvement in clinical symptoms were 8, 39, and 66, respectively.
S, Egawa   +6 more
openaire   +2 more sources

Management of brain metastases

Current Neurology and Neuroscience Reports, 2009
Brain metastases represent a common and devastating complication of cancer. With advances in surgery, radiology, and medical and radiation oncology, the number of treatment options have greatly increased. In addition, the prognosis for patients can vary widely depending on factors such as the number of lesions, extent of extracranial disease, age, and ...
John H, Suh   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy